Understanding Candidozyma (Candida) auris: genomic evolution, antifungal resistance and the growing challenges in global infection control - PubMed
8 hours ago
- #infection control
- #antifungal resistance
- #Candida auris
- Candida auris, renamed Candidozyma auris, is an emerging multidrug-resistant fungal pathogen first identified in Japan in 2009.
- It persists on human skin and surfaces, resists antifungals like fluconazole, forms biofilms, and causes hospital outbreaks with high mortality.
- Key uncertainties include its origin, transmission routes, and optimal control strategies, necessitating improved genomic surveillance and antifungal approaches.